Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a type of dementia caused by a brain disease (such as Alzheimer's disease), based on recognised medical guidelines
- You have a regular, reliable caregiver who can attend follow-up appointments with you
Who may not be able to join:
- You have not been diagnosed with dementia, including if you have only been told you have mild memory or thinking problems (sometimes called MCI or mild cognitive impairment)
- You have a serious illness affecting your whole body, or you have significant vision or hearing difficulties that would make it hard to complete the study's tests and check-ups
- You do not have a regular, reliable caregiver
- You are not willing to give your agreement (consent) to take part in the trial
- Doctors estimate that your life expectancy may be less than 2 years
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chenhui Mao, Doctor, Peking Union Medical College Hospital
Phone: +86018611895308
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The incidence of dementia; The relationship between lifestyles, stress (stressful events and their degree) and dementia; Risk factors for dementia; Cognitive decline; Functional decline; Changes in the Neuropsychiatric Index (NPI); Changes in the Hospital Anxiety and Depression scale (HAD); Changes in the Cornell Scale for dementia; Tau and Beta-amyloid biomarkers in CSF; Tau biomarkers in serum; CSF collection for assessing new dementia biomarker; Serum collection for assessing new dementia biomarker; Urine collection for assessing new dementia biomarker; Skin collection for assessing new dem...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.